Células Madre
Células Madre is a Venezuelan private healthcare company that collects, processes, and cryopreserves umbilical cord blood and tissue stem cells for expectant families, operating laboratories in Maracay (LVCM) and Miami (GeneCell International), with complementary newborn screening and telemedicine services.
- Company typePrivate
- Founded2006
- HeadquartersMaracay, Venezuela
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Células Madre does
Células Madre C.A. is a Venezuelan private healthcare company founded in 2006 and headquartered in Maracay, Estado Aragua, that operates a stem cell banking and neonatal diagnostics business. Its core service is the cryopreservation of hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue at the moment of birth, performed at the company's wholly-owned LVCM laboratory in Maracay using controlled-rate stage-by-stage freezing and stored in nitrogen-backed cryogenic tanks. Quality control relies on flow cytometry (CD34+/CD45+ immunophenotyping) and a serology panel covering HIV, HTLV I/II, Hepatitis B and C, CMV, Syphilis, and Chagas, with samples processed without Heparin.
The company monetizes through one-time processing and contract fees plus recurring annual storage fees on the installed sample base, supplemented by a 60-disease neonatal metabolic screening partnership with Perkin Elmer's Metabolic Diseases Institute, a stem cell therapy service for ~80 treatable conditions, telemedicine consultations via Zoom, and a $30-per-referral program called Plan Mi Amiga Embarazada. Go-to-market combines a zoned direct sales force (five Venezuelan regions with named reps), sales offices embedded in major maternity hospitals including Maternidad La Floresta, in-house courier logistics for kit delivery and pickup, and a distributed promoter network drawn from the maternal-infant professional community.
Operations are supported by a second wholly-owned laboratory, GeneCell International LLC in Miami, Florida, which provides international-grade processing, advanced security and temperature-monitoring systems, and serves as a backup facility for Venezuelan clients while extending the addressable market into the U.S. The company claims 15,000+ satisfied customers, no publicly disclosed revenue or funding, and operates without any disclosed institutional investors or parent entity.
Células Madre firmographics
Firmographics- Name
- Células Madre
- Legal name
- Células Madre C.A.
- Website
- https://celulasmadrela.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Células Madre is a Venezuelan private healthcare company that collects, processes, and cryopreserves umbilical cord blood and tissue stem cells for expectant families, operating laboratories in Maracay (LVCM) and Miami (GeneCell International), with complementary newborn screening and telemedicine services.
- Ownership category
- akta.pro rank
Células Madre industry classification
Industry- Product category
- Stem Cell Banking
- NAICS
- Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Newborn Screening & Genetic Public Health Laboratories (HLAJAIAJ)
Keywords
Where Células Madre is headquartered
LocationHeadquarters
- HQ city
- Maracay
- HQ country
- Venezuela
- HQ region
- Latin America
Offices5 records
Markets served
Células Madre business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Criopreservación de Células Madre del Cordón Umbilical: Core revenue stream from processing and cryogenic storage of stem cells from umbilical cord blood. One-time collection and processing fee plus recurring annual storage fees.
- Criopreservación de Tejido del Cordón Umbilical: Additional cryopreservation service for umbilical cord tissue containing mesenchymal stem cells, offered as an add-on to blood storage.
- Screening Neonatal (Prueba del Talón): Newborn metabolic screening test analyzing up to 60 diseases. Results delivered via email within 10 days. Samples processed at Perkin Elmer's Metabolic Diseases Institute.
- Programa de Referidos (Plan Mi Amiga Embarazada): Referral commission revenue: promoters earn $30 per effective referral of a pregnant woman who purchases cryopreservation services. Commission paid via Zelle, PayPal, or bank transfer in USD.
Go-to-market motion4 records
Distribution channels5 records
Marketing channels10 records
Células Madre product offering
Product offeringCore offering
Células Madre C.A. is a Venezuelan healthcare company that collects, processes, and cryopreserves stem cells from umbilical cord blood and tissue at the time of birth, providing long-term storage for potential future medical use. The company also offers newborn metabolic screening for up to 60 diseases and telemedicine consultations with stem cell specialists. Operations are conducted through two laboratories—LVCM (Laboratorio Venezolano de Células Madre) in Maracay, Venezuela and GeneCell International LLC in Miami, Florida—and are distributed via a field sales force, a referral program, and direct digital channels.
Product overview
Células Madre C.A. operates a unified service portfolio centered on cord blood and tissue stem cell cryopreservation, with complementary screening and telemedicine offerings. The core service—Criopreservación de Células Madre del Cordón Umbilical—provides collection, processing, and long-term storage of umbilical cord stem cells, augmented by Almacenamiento de Tejido del Cordón Umbilical for mesenchymal stem cells. Add-on modules include Screening Neonatal (60-disease metabolic screening via Perkin Elmer) and telemedicine consultations. Operations are supported by two laboratory brands: LVCM (Laboratorio Venezolano de Células Madre) in Maracay, Venezuela, handling Venezuelan client samples; and GeneCell International LLC in Miami, Florida, processing additional sample types including dental pulp and adipose tissue. A referral program (Plan Mi Amiga Embarazada) incentivizes customer acquisition.
Differentiator
Problem solved
Functional benefit
Brands
- LVCM Laboratorio: Venezuelan laboratory specializing in processing and cryopreservation of umbilical cord blood stem cells
- GeneCell International
- Plan Mi Amiga Embarazada
Products and services
- Criopreservación de Células Madre del Cordón Umbilical (Cord Blood Stem Cell Cryopreservation) Cryopreservation service for stem cells extracted from umbilical cord blood at birth, with processing and long-term storage for potential future medical treatment of 80+ diseases. Targeted at expectant parents and families in Venezuela.
- Almacenamiento de Tejido del Cordón Umbilical (Cord Tissue Storage) Storage service for umbilical cord tissue containing mesenchymal stem cells used in regenerative medicine and tissue engineering applications. Offered as an add-on to cord blood storage.
- Screening Neonatal (Newborn Metabolic Screening) Newborn screening test (heel prick) analyzing up to 60 metabolic diseases recommended by March of Dimes and the American College of Medical Genetics (ACMG). Samples processed by Perkin Elmer's Metabolic Diseases Institute with results delivered within 10 days.
- Terapia con Células Madre (Stem Cell Therapy) Stem cell therapy services utilizing preserved cord blood and tissue stem cells for treatment of approximately 80 diseases including cancers, bone marrow insufficiency syndromes, immunodeficiencies, and metabolic disorders.
- Servicios de Telemedicina (Telemedicine Services) Telemedicine consultation services enabling clients to have virtual consultations with stem cell specialists via Zoom video platform. Free consultation scheduling available via website.
Quantifiable outcome
- 35,000+ treatments performed worldwide using cord blood stem cells
- +3 more outcomes
Companies that use Células Madre
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Células Madre technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Células Madre partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GeneCell International LLCcoreGeneCell International LLC is a high-tech laboratory in Miami, Florida operated as a sister/referral partner facility for Células Madre. It provides processing and cryopreservation of umbilical cord blood stem cells, dental pulp stem cells, adipose tissue, and other cryopreservable cells. Offers international-grade quality standards, integrated security systems, temperature monitoring, alarm systems, and nitrogen backup tanks. Células Madre uses GeneCell as a backup storage option for Venezuelan clients.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Células Madre competitors and assessment
Company assessmentDirect peers
- Cryo-Cell International: One of the oldest and largest publicly-listed cord blood banks in the US, offering cord blood and cord tissue cryopreservation with FDA-cleared processing. Highly comparable in core service (private family cord blood banking) and revenue model (one-time processing + recurring storage).
- Smart Cells International: UK private cord blood bank offering cord blood and tissue storage with international collection partnerships. Comparable international family-banking model with similar technology (controlled-rate freezing) and recurring storage revenue model.
- ViaCord (PerkinElmer): Family cord blood banking service owned by PerkinElmer. Directly comparable service offering, and notably a sibling entity of PerkinElmer's Metabolic Diseases Institute — the lab partner Células Madre already uses for neonatal screening.
- Cord Blood Registry (CBR) / California Cryobank: Largest US family cord blood bank with over 1 million stored samples. Comparable in service offering (cord blood + cord tissue storage) and customer profile (expectant parents), with significantly greater scale and AABB accreditation.
- Americord Registry: US-based private cord blood and cord tissue bank with similar product breadth (cord blood, cord tissue, exosome/placental tissue) and direct-to-consumer sales model. Comparable in technology stack and target demographic.
- Future Health Biobank: UK- and Switzerland-based private stem cell bank storing cord blood, cord tissue, and dental pulp. Comparable multi-tissue storage offering and recurring revenue model; serves as a useful international benchmark.
Broad incumbents
- StemCyte: Hybrid public/private cord blood bank operating across the US and internationally, with both family storage and a public registry. Comparable in core storage technology, broader in regulatory positioning (FDA, FACT).
Regional players
- Cells4Life: UK-based private cord blood and cord tissue bank with comparable service breadth. Functions as a regional peer outside LatAm but is a useful benchmark for European stem cell storage pricing and recurring storage economics.
- CordVida (Brazil): Brazilian private cord blood bank operating in the largest Latin American market. Closest geographic peer to Células Madre in South America and useful benchmark for LatAm family cord banking pricing and adoption dynamics.
Others
- CryoHoldco / Cryoport: Provider of cryogenic logistics and cold-chain solutions for the cell and gene therapy industry. Adjacent enabling company that supplies the temperature-controlled transport infrastructure on which cord blood banks depend.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Células Madre social profiles
Digital presenceCélulas Madre compliance and trust
Trust signalCompliance1 record
Células Madre financial estimates
Financial estimateRevenue estimate
Valuation estimate
Células Madre leadership team
Management profileNumber of profiles
Células Madre subsidiaries and ownership
Company hierarchySubsidiaries2 records
Células Madre funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Células Madre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Células Madre
What does Células Madre do?
Células Madre C.A. is a Venezuelan healthcare company that collects, processes, and cryopreserves stem cells from umbilical cord blood and tissue at the time of birth, providing long-term storage for potential future medical use. The company also offers newborn metabolic screening for up to 60 diseases and telemedicine consultations with stem cell specialists. Operations are conducted through two laboratories—LVCM (Laboratorio Venezolano de Células Madre) in Maracay, Venezuela and GeneCell International LLC in Miami, Florida—and are distributed via a field sales force, a referral program, and direct digital channels.
Is Células Madre a public or private company?
Células Madre is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Células Madre founded?
Células Madre was founded in 2006. It employs 101 to 250 people.
Where is Células Madre based?
Células Madre is headquartered in Maracay, Venezuela, in the Latin America region.
How does Células Madre make money?
Four revenue lines are on record. Criopreservación de Células Madre del Cordón Umbilical is the primary driver. The others are criopreservación de Tejido del Cordón Umbilical, screening Neonatal (Prueba del Talón) and programa de Referidos (Plan Mi Amiga Embarazada).
Who are Células Madre's main competitors?
Direct peers on record are Cryo-Cell International, Smart Cells International, ViaCord (PerkinElmer), Cord Blood Registry (CBR) / California Cryobank, Americord Registry and Future Health Biobank. StemCyte is listed as a broad incumbent. Regional players are Cells4Life and CordVida (Brazil). CryoHoldco / Cryoport is listed as an others.
Does Células Madre have an API?
No public API is recorded for Células Madre.
What industry is Células Madre in?
Células Madre's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 621991 and its SIC code is 8071.